Last updated on June 2019

Post-Marketing Surveillance Study of Fycompa Film-coated Tablets in Korean Patients

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Epilepsy
  • Age: Between 12 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Participants with approved indication for Fycompa in Korea: the adjunctive therapy for treatment of partial-onset seizures with or without secondarily generalized seizures in participants with epilepsy aged 12 years and older
  • Participants who have written consent for use of personal and medical information for the study purpose

Exclusion Criteria:

  • Hypersensitivity to the active substance or to any of the excipients of this medicine
  • Fycompa contains lactose; therefore, participants with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medicine
  • Other participants judged to be inadequate to participate in the study by doctor

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.